Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome

Lauren A Cammaert, Angus D. MacLeod, Graham A. Mackay, Callum W. Duncan

Research output: Contribution to journalArticle

Abstract

A 48-year-old man presented with severe limb, bulbar, and respiratory weakness requiring intubation and ventilation. Decrement was seen on repetitive nerve stimulation, but tested muscles were too weak for voluntary activation and tetanic stimulation was not tolerated. Positive voltage-gated calcium channel and SOX1 antibodies confirmed Lambert-Eaton myasthenic syndrome (LEMS). Despite corticosteroids, 3,4-diaminopyridine, and plasma exchange, severe bulbar weakness persisted, the patient remained tracheostomy-dependent, and he developed marked tongue atrophy (figure, A). Small cell lung cancer was subsequently confirmed. Radiotherapy 3 months after presentation resulted in recovery of bulbar function, improvement in tongue atrophy, and tracheostomy decannulation with improvement sustained 10 months later (figure, B and C). Tongue atrophy uncommonly occurs in generalized myasthenia gravis1 but has not been previously reported in LEMS. The underlying mechanism may be neurogenic atrophy due to severe neuromuscular junction dysfunction.2

Original languageEnglish
Pages (from-to)459-460
Number of pages2
JournalNeurology
Volume93
Issue number10
Early online date2 Sep 2019
DOIs
Publication statusPublished - 3 Sep 2019

Fingerprint

Lambert-Eaton Myasthenic Syndrome
Tongue
Atrophy
Tracheostomy
Plasma Exchange
Neuromuscular Junction
Recovery of Function
Small Cell Lung Carcinoma
Calcium Channels
Intubation
Ventilation
Adrenal Cortex Hormones
Radiotherapy
Extremities
Muscles
Antibodies

Cite this

Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome. / Cammaert, Lauren A; MacLeod, Angus D.; Mackay, Graham A.; Duncan, Callum W.

In: Neurology, Vol. 93, No. 10, 03.09.2019, p. 459-460.

Research output: Contribution to journalArticle

Cammaert, Lauren A ; MacLeod, Angus D. ; Mackay, Graham A. ; Duncan, Callum W. / Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome. In: Neurology. 2019 ; Vol. 93, No. 10. pp. 459-460.
@article{bc6103c563f649f2a4a01fb132dbdf14,
title = "Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome",
abstract = "A 48-year-old man presented with severe limb, bulbar, and respiratory weakness requiring intubation and ventilation. Decrement was seen on repetitive nerve stimulation, but tested muscles were too weak for voluntary activation and tetanic stimulation was not tolerated. Positive voltage-gated calcium channel and SOX1 antibodies confirmed Lambert-Eaton myasthenic syndrome (LEMS). Despite corticosteroids, 3,4-diaminopyridine, and plasma exchange, severe bulbar weakness persisted, the patient remained tracheostomy-dependent, and he developed marked tongue atrophy (figure, A). Small cell lung cancer was subsequently confirmed. Radiotherapy 3 months after presentation resulted in recovery of bulbar function, improvement in tongue atrophy, and tracheostomy decannulation with improvement sustained 10 months later (figure, B and C). Tongue atrophy uncommonly occurs in generalized myasthenia gravis1 but has not been previously reported in LEMS. The underlying mechanism may be neurogenic atrophy due to severe neuromuscular junction dysfunction.2",
author = "Cammaert, {Lauren A} and MacLeod, {Angus D.} and Mackay, {Graham A.} and Duncan, {Callum W.}",
year = "2019",
month = "9",
day = "3",
doi = "10.1212/WNL.0000000000008076",
language = "English",
volume = "93",
pages = "459--460",
journal = "Neurology",
issn = "0028-3878",
publisher = "AAN Enterprises",
number = "10",

}

TY - JOUR

T1 - Reversible tongue atrophy in Lambert-Eaton myasthenic syndrome

AU - Cammaert, Lauren A

AU - MacLeod, Angus D.

AU - Mackay, Graham A.

AU - Duncan, Callum W.

PY - 2019/9/3

Y1 - 2019/9/3

N2 - A 48-year-old man presented with severe limb, bulbar, and respiratory weakness requiring intubation and ventilation. Decrement was seen on repetitive nerve stimulation, but tested muscles were too weak for voluntary activation and tetanic stimulation was not tolerated. Positive voltage-gated calcium channel and SOX1 antibodies confirmed Lambert-Eaton myasthenic syndrome (LEMS). Despite corticosteroids, 3,4-diaminopyridine, and plasma exchange, severe bulbar weakness persisted, the patient remained tracheostomy-dependent, and he developed marked tongue atrophy (figure, A). Small cell lung cancer was subsequently confirmed. Radiotherapy 3 months after presentation resulted in recovery of bulbar function, improvement in tongue atrophy, and tracheostomy decannulation with improvement sustained 10 months later (figure, B and C). Tongue atrophy uncommonly occurs in generalized myasthenia gravis1 but has not been previously reported in LEMS. The underlying mechanism may be neurogenic atrophy due to severe neuromuscular junction dysfunction.2

AB - A 48-year-old man presented with severe limb, bulbar, and respiratory weakness requiring intubation and ventilation. Decrement was seen on repetitive nerve stimulation, but tested muscles were too weak for voluntary activation and tetanic stimulation was not tolerated. Positive voltage-gated calcium channel and SOX1 antibodies confirmed Lambert-Eaton myasthenic syndrome (LEMS). Despite corticosteroids, 3,4-diaminopyridine, and plasma exchange, severe bulbar weakness persisted, the patient remained tracheostomy-dependent, and he developed marked tongue atrophy (figure, A). Small cell lung cancer was subsequently confirmed. Radiotherapy 3 months after presentation resulted in recovery of bulbar function, improvement in tongue atrophy, and tracheostomy decannulation with improvement sustained 10 months later (figure, B and C). Tongue atrophy uncommonly occurs in generalized myasthenia gravis1 but has not been previously reported in LEMS. The underlying mechanism may be neurogenic atrophy due to severe neuromuscular junction dysfunction.2

U2 - 10.1212/WNL.0000000000008076

DO - 10.1212/WNL.0000000000008076

M3 - Article

C2 - 31477611

VL - 93

SP - 459

EP - 460

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 10

ER -